MTOR and cancer: Molecular mechanisms and cellular properties that contribute to radioresistance of prostate cancer are only partly understood involving activations of signaling pathways such as PI3K/Akt and mTOR, alterations of DNA repair pathways, autophagy, and epithelial-mesenchymal transition, and the potential existence of cancer stem cells [5].